India Boosts Pharma-MedTech Innovation with PRIP Workshop
ECONOMY & POLICY

India Boosts Pharma-MedTech Innovation with PRIP Workshop

The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilisers, Government of India, held a workshop on the Promotion of Research and Innovation in the Pharma-MedTech Sector (PRIP) Scheme on March 12, 2025. Senior officials from key government departments participated, including Shri Amit Agrawal, Secretary, Department of Pharmaceuticals; Prof. Abhay Karandikar, Secretary, Department of Science and Technology (DST); Shri S. Krishnan, Secretary, Ministry of Electronics and Information Technology (MeitY); Dr. N. Kalaiselvi, Secretary, Department of Scientific and Industrial Research (DSIR) and Director General of CSIR; and Dr. Rajiv Bahl, Secretary, Department of Health Research (DHR) and DG, ICMR.

The workshop focused on strengthening India’s innovation ecosystem in pharmaceuticals and medical technology. Shri Amit Agrawal highlighted the sector's rapid growth, noting the rising global share of advanced technologies like antibody-drug conjugates and gene therapy — projected to reach 20% of the top-100 drugs by value by 2030. He also pointed to the remarkable tenfold increase in Indian healthcare and life sciences startups, from 900 in 2020 to over 10,000 in 2024.

The PRIP scheme aims to build on this momentum with support from initiatives like CSIR’s INTENT for clinical trials, ICMR’s MedTech Mitra and Patent Mitra, and funding programs like DST’s Quantum Computing Mission and MeitY’s TIDE 2.0 and SAMRIDH. Leaders from DST, MeitY, DHR, and CSIR stressed the importance of digital health, AI, data-driven technologies, and industry-academia collaboration in driving innovation and commercialisation of research.

The workshop hosted over 100 participants from top scientific institutions, including NIPERs, IITs, CSIR labs, and government bodies, with discussions on emerging pharmaceutical and MedTech trends and strategies to transform research into market-ready products. Participants were invited to submit suggestions via the Expression of Interest (EoI) form on the Department of Pharmaceuticals’ website, open until April 7, 2025.

(PIB)       

The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilisers, Government of India, held a workshop on the Promotion of Research and Innovation in the Pharma-MedTech Sector (PRIP) Scheme on March 12, 2025. Senior officials from key government departments participated, including Shri Amit Agrawal, Secretary, Department of Pharmaceuticals; Prof. Abhay Karandikar, Secretary, Department of Science and Technology (DST); Shri S. Krishnan, Secretary, Ministry of Electronics and Information Technology (MeitY); Dr. N. Kalaiselvi, Secretary, Department of Scientific and Industrial Research (DSIR) and Director General of CSIR; and Dr. Rajiv Bahl, Secretary, Department of Health Research (DHR) and DG, ICMR.The workshop focused on strengthening India’s innovation ecosystem in pharmaceuticals and medical technology. Shri Amit Agrawal highlighted the sector's rapid growth, noting the rising global share of advanced technologies like antibody-drug conjugates and gene therapy — projected to reach 20% of the top-100 drugs by value by 2030. He also pointed to the remarkable tenfold increase in Indian healthcare and life sciences startups, from 900 in 2020 to over 10,000 in 2024.The PRIP scheme aims to build on this momentum with support from initiatives like CSIR’s INTENT for clinical trials, ICMR’s MedTech Mitra and Patent Mitra, and funding programs like DST’s Quantum Computing Mission and MeitY’s TIDE 2.0 and SAMRIDH. Leaders from DST, MeitY, DHR, and CSIR stressed the importance of digital health, AI, data-driven technologies, and industry-academia collaboration in driving innovation and commercialisation of research.The workshop hosted over 100 participants from top scientific institutions, including NIPERs, IITs, CSIR labs, and government bodies, with discussions on emerging pharmaceutical and MedTech trends and strategies to transform research into market-ready products. Participants were invited to submit suggestions via the Expression of Interest (EoI) form on the Department of Pharmaceuticals’ website, open until April 7, 2025.(PIB)       

Next Story
Equipment

Kobelco CE India Marks Milestone with 20,000th Excavator

Kobelco Construction Equipment India (KCEI), a subsidiary of Japan-based Kobelco Construction Machinery Co., has reached a significant production milestone by rolling out its 20,000th excavator at its manufacturing plant in Sri City, Andhra Pradesh. This facility serves both domestic and international markets, reinforcing India’s role as a key production center for Kobelco.Takemichi Hirakawa, Managing Director & CEO, Kobelco Construction Equipment India, said, ""Reaching the 20,000th excavator production milestone reflects our commitment to delivering high-quality construction equipment...

Next Story
Infrastructure Transport

Cabinet Approves Highway from JNPA to Chowk in Maharashtra

The Cabinet Committee on Economic Affairs, chaired by Prime Minister Narendra Modi, has approved the construction of a 6-lane access-controlled Greenfield High-Speed National Highway from JNPA Port (Pagote) to Chowk in Maharashtra. The 29.219 km project will be developed on a Build, Operate, and Transfer (BOT) toll model at an estimated cost of Rs 45 billion. As part of the PM Gati Shakti National Master Plan, the project aims to enhance road connectivity to major ports, addressing increasing container traffic at JNPA and the upcoming Navi Mumbai International Airport. Currently, heavy co..

Next Story
Infrastructure Urban

Effective Implementation of MGNREGA in the Last Decade

The Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA), enacted in 2005, aims to enhance livelihood security in rural areas by guaranteeing at least 100 days of wage employment per year to willing adult members of rural households performing unskilled manual labour. Over the years, the government has significantly increased budget allocations for the scheme. From Rs 113 billion in 2006-07, the allocation rose to Rs 330 billion in 2013-14 and reached a record Rs 860 billion in 2024-25. During the COVID-19 pandemic in 2020-21, the government spent Rs 1,110 billion under MGNREG..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?